Divi's Laboratories [DIVISLAB] vs Torrent [TORNTPHARM] Detailed Stock Comparison

Divi's Laboratories
NSE
Loading...

Torrent
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Divi's Laboratories wins in 9 metrics, Torrent wins in 11 metrics, with 0 ties. Torrent appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Divi's Laboratories | Torrent | Better |
---|---|---|---|
P/E Ratio (TTM) | 70.79 | 61.35 | Torrent |
Price-to-Book Ratio | 10.93 | 16.15 | Divi's Laboratories |
Debt-to-Equity Ratio | 0.03 | 42.81 | Divi's Laboratories |
PEG Ratio | 2.67 | 3.09 | Divi's Laboratories |
EV/EBITDA | 51.97 | 32.95 | Torrent |
Profit Margin (TTM) | 23.89% | 16.92% | Divi's Laboratories |
Operating Margin (TTM) | 25.60% | 26.15% | Torrent |
EBITDA Margin (TTM) | 25.60% | 26.15% | Torrent |
Return on Equity | 14.64% | 25.18% | Torrent |
Return on Assets (TTM) | 12.94% | 12.75% | Divi's Laboratories |
Free Cash Flow (TTM) | $2.15B | $19.73B | Torrent |
Dividend Yield | 0.91% | 17.47% | Torrent |
1-Year Return | 25.20% | 9.02% | Divi's Laboratories |
Price-to-Sales Ratio (TTM) | 16.95 | 10.36 | Torrent |
Enterprise Value | $1,592.76B | $1,251.80B | Divi's Laboratories |
EV/Revenue Ratio | 16.50 | 10.58 | Torrent |
Gross Profit Margin (TTM) | 60.33% | 75.26% | Torrent |
Revenue per Share (TTM) | $363 | $350 | Divi's Laboratories |
Earnings per Share (Diluted) | $87.08 | $59.05 | Divi's Laboratories |
Beta (Stock Volatility) | 0.27 | 0.13 | Torrent |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Divi's Laboratories vs Torrent Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Divi's Laboratories | -1.26% | 1.99% | -9.10% | -7.61% | 2.44% | 0.11% |
Torrent | 0.33% | 0.70% | 3.62% | 10.56% | 17.02% | 6.82% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Divi's Laboratories | 25.20% | 69.46% | 85.76% | 440.94% | 1,532.61% | 8,233.79% |
Torrent | 9.02% | 135.92% | 34.77% | 126.15% | 1,259.49% | 5,127.77% |
Performance & Financial Health Analysis: Divi's Laboratories vs Torrent
Metric | DIVISLAB | TORNTPHARM |
---|---|---|
Market Information | ||
Market Cap | ₹1.64T | ₹1.23T |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 557,925 | 315,811 |
90 Day Avg. Volume | 372,093 | 466,564 |
Last Close | ₹6,005.00 | ₹3,663.80 |
52 Week Range | ₹4,663.30 - ₹7,071.50 | ₹2,886.45 - ₹3,787.90 |
% from 52W High | -15.08% | -3.28% |
All-Time High | ₹7,071.50 (Jul 08, 2025) | ₹3,787.90 (Jul 30, 2025) |
% from All-Time High | -15.08% | -3.28% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.14% | 0.11% |
Quarterly Earnings Growth | 0.27% | 0.20% |
Financial Health | ||
Profit Margin (TTM) | 0.24% | 0.17% |
Operating Margin (TTM) | 0.26% | 0.26% |
Return on Equity (TTM) | 0.15% | 0.25% |
Debt to Equity (MRQ) | 0.03 | 42.81 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹563.87 | ₹224.28 |
Cash per Share (MRQ) | ₹132.86 | ₹20.33 |
Operating Cash Flow (TTM) | ₹19.67B | ₹27.02B |
Levered Free Cash Flow (TTM) | ₹21.91B | ₹19.11B |
Dividends | ||
Last 12-Month Dividend Yield | 0.91% | 17.47% |
Last 12-Month Dividend | ₹60.00 | ₹552.76 |
Valuation & Enterprise Metrics Analysis: Divi's Laboratories vs Torrent
Metric | DIVISLAB | TORNTPHARM |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 70.79 | 61.35 |
Forward P/E | 109.49 | 40.52 |
PEG Ratio | 2.67 | 3.09 |
Price to Sales (TTM) | 16.95 | 10.36 |
Price to Book (MRQ) | 10.93 | 16.15 |
Market Capitalization | ||
Market Capitalization | ₹1.64T | ₹1.23T |
Enterprise Value | ₹1.59T | ₹1.25T |
Enterprise Value Metrics | ||
Enterprise to Revenue | 16.50 | 10.58 |
Enterprise to EBITDA | 51.97 | 32.95 |
Risk & Other Metrics | ||
Beta | 0.27 | 0.13 |
Book Value per Share (MRQ) | ₹563.87 | ₹224.28 |
Financial Statements Comparison: Divi's Laboratories vs Torrent
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | DIVISLAB | TORNTPHARM |
---|---|---|
Revenue/Sales | ₹24.10B | ₹31.28B |
Cost of Goods Sold | ₹9.56B | ₹7.74B |
Gross Profit | ₹14.54B | ₹23.54B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹6.17B | ₹8.31B |
EBITDA | ₹8.48B | ₹9.95B |
Pre-Tax Income | ₹7.33B | ₹7.38B |
Income Tax | ₹1.88B | ₹1.90B |
Net Income (Profit) | ₹5.45B | ₹5.48B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | DIVISLAB | TORNTPHARM |
---|---|---|
Cash & Equivalents | ₹4.15B | ₹5.73B |
Total Current Assets | ₹100.81B | ₹56.23B |
Total Current Liabilities | ₹14.52B | ₹47.17B |
Long-Term Debt | ₹20.00M | ₹13.38B |
Total Shareholders Equity | ₹149.69B | ₹75.91B |
Retained Earnings | ₹134.00B | N/A |
Property, Plant & Equipment | ₹3.19B | ₹2.99B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | DIVISLAB | TORNTPHARM |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | DIVISLAB | TORNTPHARM |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 557,925 | 315,811 |
Average Daily Volume (90 Day) | 372,093 | 466,564 |
Shares Outstanding | 265.47M | 338.45M |
Float Shares | 120.74M | 103.96M |
% Held by Insiders | 0.52% | 0.71% |
% Held by Institutions | 0.29% | 0.15% |
Dividend Analysis & Yield Comparison: Divi's Laboratories vs Torrent
Metric | DIVISLAB | TORNTPHARM |
---|---|---|
Last 12-Month Dividend | ₹60.00 | ₹552.76 |
Last 12-Month Dividend Yield | 0.91% | 17.47% |
3-Year Avg Annual Dividend | ₹50.00 | ₹198.92 |
3-Year Avg Dividend Yield | 0.70% | 3.27% |
3-Year Total Dividends | ₹150.00 | ₹596.76 |
Ex-Dividend Date | Jul 25, 2025 | Jun 20, 2025 |